Wuxi Biologics highlighted their highly integrated and scaled platform, allowing for end-to-end research, development and manufacturing of complex biologics.

The following slide deck was published by American Electric Power Company, Inc. in conjunction with their 2025 Q3 earnings call.

ROCKVILLE, Md., Oct. 20, 2025 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Innovative educators know that unless you’re a designer or scripting wizard, building a presentation from scratch can be tedious, time-consuming, and uninspired. We deserve better. With AI at our ...

Born in the 8-bit era, raised by the 16-bit era, and perfected by the 32-bit era, Cory's roots grew from the likes Sonic the Hedgehog and Mega Man to the world of Resident Evil and Castlevania. Owning ...

* Note: one patient in 0.6/1/1.5mg/kg group finished treatment without at least one post-baseline tumor assessment. Higher ORR and PFS were observed in lung adenocarcinoma patients with a history of ...

SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...

In terms of safety, among participants receiving monotherapy and combination therapy, 19 (27.9%) and 26 (35.6%) reported treatment-related adverse events (TRAEs) of Grade 3 or higher, respectively.